Blood Test Order and Culture Contamination

May 28, 2019 updated by: Shaare Zedek Medical Center

A Randomized Controlled Study of Blood Test Draw Order to Reduce Blood Culture Contamination

A randomized partially controlled study to examine the effect of blood diversion into a heparin lithium tube on the incidence of blood culture contamination.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

970

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Jerusalem, Israel
        • Shaare Zedek Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age > 18
  • Presence in Emergency Room during extended office hours (0800-2000 on weekdays(
  • Clinical requirement for Blood culture and biochemistry tests from venepuncture

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
NO_INTERVENTION: Control Group
Blood culture obtained as first test after venipuncture and prior to biochemistry test
EXPERIMENTAL: Diversion Group
Biochemistry test obtained as first test after venepuncture and prior to blood culture
Diversion of initial blood obtained at venipuncture to biochemistry tube in order to try and reduce incidence of blood culture contamination

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood culture contamination
Time Frame: up to 7 days from obtaining blood culture
Growth of bacteria defined as blood culture contaminants (for example coagulase negative staphylococci in one bottle only).
up to 7 days from obtaining blood culture

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient length of stay
Time Frame: up to 3 months from arrival
Length of stay from arrival at Emergency room until discharge in hours
up to 3 months from arrival

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 1, 2018

Primary Completion (ACTUAL)

February 28, 2019

Study Completion (ACTUAL)

February 28, 2019

Study Registration Dates

First Submitted

May 21, 2019

First Submitted That Met QC Criteria

May 28, 2019

First Posted (ACTUAL)

May 29, 2019

Study Record Updates

Last Update Posted (ACTUAL)

May 29, 2019

Last Update Submitted That Met QC Criteria

May 28, 2019

Last Verified

September 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 0177-18-SZMC

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Blood Culture Contamination

Clinical Trials on Blood diversion

3
Subscribe